A combination of quinidine/mexiletine reduces arrhythmia in dilated cardiomyopathy in two patients with R814W SCN5A mutation.

MLA

Zakrzewska-Koperska, Joanna, et al. “A Combination of Quinidine/Mexiletine Reduces Arrhythmia in Dilated Cardiomyopathy in Two Patients with R814W SCN5A Mutation.” ESC Heart Failure, vol. 7, no. 6, Dec. 2020, pp. 4326–35. EBSCOhost, https://doi.org/10.1002/ehf2.12993.

APA

Zakrzewska-Koperska, J., Bilińska, Z. T., Truszkowska, G. T., Franaszczyk, M., Elikowski, W., Warmiński, G., Kalin, K., Urbanek, P., Bodalski, R., Orczykowski, M., Szumowski, Ł., Płoski, R., & Bilińska, M. (2020). A combination of quinidine/mexiletine reduces arrhythmia in dilated cardiomyopathy in two patients with R814W SCN5A mutation. ESC Heart Failure, 7(6), 4326–4335. https://doi.org/10.1002/ehf2.12993

Chicago

Zakrzewska-Koperska, Joanna, Zofia T Bilińska, Grażyna T Truszkowska, Maria Franaszczyk, Waldemar Elikowski, Grzegorz Warmiński, Katarzyna Kalin, et al. 2020. “A Combination of Quinidine/Mexiletine Reduces Arrhythmia in Dilated Cardiomyopathy in Two Patients with R814W SCN5A Mutation.” ESC Heart Failure 7 (6): 4326–35. doi:10.1002/ehf2.12993.